Author

K. Oresic Bender

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Research Focus:ecology & biodiversity· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:metagenomics· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. J. Hryckowian· 1 shared J. L. Sonnenburg· 1 shared M. Bogyo· 1 shared M. Garland· 1 shared M. Tholen· 1 shared S. Loscher· 1 shared W. W. Van Treuren· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. J. Hryckowian

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The clinical drug candidate ebselen attenuates inflammation and promotes microbiome recovery after antibiotic treatment for Clostridium difficile infection

M. Garland, A. J. Hryckowian, M. Tholen, S. Loscher, W. W. Van Treuren, K. Oresic Bender, J. L. Sonnenburg, M. Bogyo

This study shows ebselen reduces CDI recurrence and colitis in hamsters and promotes microbiome recovery without altering diversity in mice.

bioRxiv · Nov 1, 2019Microbiology